Save the Date and plan to join us next year! September 13-15, 2024 Dear Colleagues, We are looking forward to gathering in person for the Washington Rheumatology Alliance Annual Meeting! Once again, we will be hosting the event at
TAKE ACTION: Sign in ‘PRO’ to Share the Savings!
Washington’s own Share the Savings bill (SB 5445, HB 1465) is a measure that will help lower the cost of prescription drugs for patients throughout the state. Share the Savings will improve the lives of Washingtonians who may struggle to
CSRO Action Alert
Earlier this year, Congressman Ami Bera, MD (D-CA-07) and Congressman Larry Bucshon, MD (R-IN-08) introduced legislation to provide relief for the large Medicare Physician Fee Schedule reimbursement cuts that are currently set to take effect on January 1, 2023. This legislation, Supporting Medicare Providers
Join us for the Arthritis Foundation Bone Bash
The Washington Rheumatology Alliance is Honored to Sponsor the 14th Annual Bone Bash! October 22nd, 2022 6:30 PM- 10:00 PM Brightwater Environmental Education and Community Center 22505 State Route 9 SE Woodinville WA, 98072-6010 The Arthritis Foundation Great West
Office of Inspector General: MAOs & Pre Authorization Requests
April 2022: Some Medicare Advantage Organization Denials of Prior Authorization Requests Raise Concerns About Beneficiary Access to Medically Necessary Care With there being the potential concern of MAOs having the ability to increase profits by denying payments and access to
Introducing Our Stories Rx
As an initial convening, Our Stories Rx is hosting a virtual roundtable conversation with Antonio Ciaccia, who served as the government affairs director for the Ohio Pharmacists Association in 2018, when a state audit revealed a PBM-led spread pricing scheme
New Medicare Changes
We are providing information that hopefully will help our members understand the 2021 Final WRVU billing codes and reimbursements slated for Rheumatologists. The final WRVU code values for E & M coding: Please notice that at the end of 2020,
Genentech Stance on Most Favored Nations (MFN) Model
On December 15, 2020, Genentech led a discussion about how the Most Favored Nations (MFN) model threatens provider and patient access to existing and future medicines; we share your concerns that this could have a detrimental impact on your practice
Downloadable Resources from the Arthritis Foundation
The Arthritis Foundation has free downloadable brochures and fact sheets through the AF Store that you can save to your office desktop. The brochures and fact sheets can be e-mailed to patients or you can print copies in-office and hand
Biosimilars Could Generate $100 Billion in Savings Over Next Five Years, New Report Finds
WASHINGTON, D.C. — A new report from the IQVIA Institute for Human Data Science has determined that biosimilars are on track to reduce drug costs by $100 billion over the next five years if their use rises. The future of this lower-cost